Global  

Trusted News Discovery Since 2008
One News Page
One News Page > Business News > Genprex inks license agreement with university researchers for potentially curative diabetes gene therapy

Genprex inks license agreement with university researchers for potentially curative diabetes gene therapy

Proactive Investors Tuesday, 11 February 2020
Genprex Inc (NASDAQ:GNPX) has signed a licensing agreement with the University of Pittsburgh for a diabetes gene therapy that could have the potential to cure Type 1 and Type 2 diabetes.  The gene therapy, developed at the Rangos Research Center at UPMC Children’s Hospital of Pittsburgh, works by reprogramming beta cells in the pancreas to restore their function, allowing them to replenish insulin levels.  “One of the biggest advantages of this gene therapy is that it could eliminate the need for insulin replacement therapy for diabetic patients,” lead researcher George Gittes said in a statement. “Lifting this huge burden for the millions of patients who must continuously monitor blood glucose levels and inject insulin daily would be a breakthrough in modern medicine. This therapy has the potential to truly disrupt the diabetes market.” READ: Genprex prioritizing Oncoprex development in combo with AstraZeneca’s Tagrisso to treat non-small cell lung cancer The therapy has been tested in mice and nonhuman primates, the company said. In studies of diabetic mice, the gene therapy approached restored normal blood glucose levels for an extended period of time, typically around four months. According to Gittes, that could translate to decades in humans. “We are excited to announce the licensing agreement with The University of Pittsburgh, and we look forward to working with Dr. Gittes and his team to develop this groundbreaking treatment for diabetes,” Genprex CEO Rodney Varner said. “At Genprex, we have always put patient needs first, focusing on ways to bring new treatment options to patient populations who have large unmet medical needs. “We believe this diabetes gene therapy may potentially become a new treatment option for the millions of diabetes patients who now must take insulin replacement therapy, and it may be effective for patients who do not benefit sufficiently from that therapy. Even more moving, the diabetes gene therapy could hold the potential to provide long term effectiveness, or even be a cure, for diabetes patients.” The Austin, Texas- & Cambridge, Massachusetts-based company said it plans to pursue potential partnerships for the development of this therapy in the US and abroad. More than 30 million Americans have diabetes, and approximately 1.5 million Americans are diagnosed with diabetes every year, according to the American Diabetes Association. Contact Andrew Kessel at [email protected]  Follow him on Twitter @andrew_kessel
0
shares
ShareTweetSavePostSend
 

You Might Like


Recent related videos from verified sources

University Of Pittsburgh Researchers Working On Coronavirus Vaccine [Video]

University Of Pittsburgh Researchers Working On Coronavirus Vaccine

The University of Pittsburgh's Center for Vaccine Research has been on the cutting edge of work being done on COVID-19; KDKA's Rick Dayton reports.

Credit: KDKA CBS 2 Pittsburgh     Duration: 02:21Published
Incredible Facts About Diabetes & How To Manage It. [Video]

Incredible Facts About Diabetes & How To Manage It.

Diabetes affects twenty-nine million Americans, while globally eighty-six million individuals have pre-diabetes, and eight million have diabetes mellitus. Fortunately, diabetes mellitus can be..

Credit: Rumble     Duration: 01:11Published

Recent related news from verified sources

Orgenesis partners with Belgium's RevaTis to develop stem cells for therapeutic use

Orgenesis Inc (NASDAQ:ORGS) is teaming up with regenerative medicine and cell therapy firm RevaTis on a new joint venture to produce certain stem cells for...
Proactive Investors

Breakthrough in unlocking genetic potential of ocean microbes

Breakthrough in unlocking genetic potential of ocean microbes
Norwich UK (SPX) Apr 07, 2020 Researchers have made a major breakthrough in developing gene-editing tools to improve our understanding of one of the most...
Energy Daily Also reported by •Newsmax

Tweets about this



Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.